| France-helene Marina Russman, MD | |
|
12115 Paramount Blvd, Downey, CA 90242-2309 | |
| (310) 294-9027 | |
| (562) 453-3059 |
| Full Name | France-helene Marina Russman |
|---|---|
| Gender | Female |
| Speciality | Pain Medicine - Pain Medicine |
| Location | 12115 Paramount Blvd, Downey, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366659880 | NPI | - | NPPES |
| A48047 | Other | CA | STATE LICENSE # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0000X | Pain Medicine - Pain Medicine | A48047 (California) | Primary |
| Entity Name | Fmr Interventional Quality Pain Management A Professional Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568958171 PECOS PAC ID: 8224389440 Enrollment ID: O20230705003308 |
News Archive
FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.
Among Chinese women who are survivors of intimate partner violence, an advocacy intervention that included empowerment sessions and telephone support from social workers did not result in a clinically meaningful improvement in depressive symptoms, according to a study in the August 4 issue of JAMA, a theme issue on violence and human rights.
Dengue Fever (DF) and Dengue Hemorrhagic Fever (DHF) are the most important vector-borne viral diseases in the World. Around 50-100 million cases appear each year putting 2.5 billion people at risk of suffering this debilitating and sometimes fatal disease.
Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, will announce results from its Phase 2/3 clinical trial of its proprietary inhaled alpha-1 antitrypsin (AAT) to treat alpha-1 antitrypsin deficiency (AATD) in Europe and Canada on Friday, May 16, 2014, at approximately 7:30 a.m. Eastern time.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| France-helene Marina Russman, MD 12415 Norwalk Blvd Unit 59600, Norwalk, CA 90652-7129 Ph: (310) 294-9027 | France-helene Marina Russman, MD 12115 Paramount Blvd, Downey, CA 90242-2309 Ph: (310) 294-9027 |
News Archive
FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.
Among Chinese women who are survivors of intimate partner violence, an advocacy intervention that included empowerment sessions and telephone support from social workers did not result in a clinically meaningful improvement in depressive symptoms, according to a study in the August 4 issue of JAMA, a theme issue on violence and human rights.
Dengue Fever (DF) and Dengue Hemorrhagic Fever (DHF) are the most important vector-borne viral diseases in the World. Around 50-100 million cases appear each year putting 2.5 billion people at risk of suffering this debilitating and sometimes fatal disease.
Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, will announce results from its Phase 2/3 clinical trial of its proprietary inhaled alpha-1 antitrypsin (AAT) to treat alpha-1 antitrypsin deficiency (AATD) in Europe and Canada on Friday, May 16, 2014, at approximately 7:30 a.m. Eastern time.
› Verified 1 days ago
Chad Lee, M.D. Pain Medicine Medicare: Medicare Enrolled Practice Location: 10441 Lakewood Blvd Ste E, Downey, CA 90241 Phone: 562-869-3585 | |
Vincent J. Valdez, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 8067 Florence Ave, Downey, CA 90240 Phone: 562-622-0095 Fax: 562-622-0087 |